Ropinirole Hydrochloride
Daten werden ergänzt – meist innerhalb einer Minute fertig
Grundinformationen
- CAS
91374-20-8- Standard-SMILES
CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl- InChIKey
XDXHAEQXIBQUEZ-UHFFFAOYSA-N- Summenformel
- C16H25ClN2O
- Durchschnittliche Molmasse
- 296,83 g/mol
- Monoisotopische Masse
- 296,1655411
Überblick
Ropinirole hydrochloride is a member of indoles.
Namen und Bezeichner
- Bevorzugter Name
- Ropinirole Hydrochloride
- IUPAC
- 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one;hydrochloride
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
91374-20-8- PubChem CID
- 68727
- DTXSID
DTXSID50238533- ChEMBL
CHEMBL1200411- ChEBI
CHEBI:8889- UNII
- D7ZD41RZI9
- EC Number
- 635-615-9
Eigenschaften
Berechnete StruktureigenschaftenWird ergänzt
- Polarare Oberfläche (TPSA)
- 32,3 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 7
- Schwere Atome
- 20
- Formalladung
- 0
- Komplexität
- 286
Experimentelle und physikochemische Eigenschaften
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 49 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Toxikologische Informationen
Toxicity Summary
Ropinirole binds the dopamine receptors D<sub>3</sub> and D<sub>2</sub>. Although the precise mechanism of action of ropinirole as a treatment for Parkinson's disease is unknown, it is believed to be related to its ability to stimulate these receptors in the striatum. This conclusion is supported by electrophysiologic studies in animals that have demonstrated that ropinirole influences striatal neuronal firing rates via activation of dopamine receptors in the striatum and the substantia nigra, the site of neurons that send projections to the striatum.
Signs and Symptoms
Symptoms of overdose include agitation, chest pain, confusion, drowsiness, facial muscle movements, grogginess, increased jerkiness of movement, symptoms of low blood pressure (dizziness, light-headedness)upon standing, nausea, and vomiting.
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Ropinirole hydrochloride
vLess-DILI-concern
4
Adverse reactions
DOI:10.1016/j.drudis.2016.02.015
Chemie und Industrie
Pharmakologische Informationen
Metabolism/Metabolites
Hepatic. Ropinirole is extensively metabolized to inactive metabolites via N -despropylation and hydroxylation pathways, largely by the P450 isoenzyme CYP1A2. N-despropyl ropinirole is the predominant metabolite found in urine (40%), followed by the carboxylic acid metabolite (10%), and the glucuronide of the hydroxy metabolite (10%). Route of Elimination: Ropinirole is extensively metabolized by the liver to inactive metabolites, and less than 10% of the administered dose is excreted as unchanged drug in urine. Half Life: 6 hours
FDA Pharmacological Classification
ROPINIROLE HYDROCHLORIDE
Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]
MeSH Pharmacological Classification
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
Drugs that bind to and activate dopamine receptors.
Verwendung und Herstellung
Anbieter100 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…